LUND, Sweden, Dec. 30, 2022 /PRNewswire/ -- Hansa Biopharma AB "Hansa" or the "Company", (NASDAQ Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announces that the Company's registered share capital and number of outstanding shares and votes have...